159 related articles for article (PubMed ID: 318057)
1. [Correlations between complement degradation products and circulating immune complexes in human glomerulonephritis].
Coppo R; De Marchi M; Alloatti S; Segoloni G; Giacchino F; Quarello F; Roccatello D; Bulzomi MR; Piccoli G
Minerva Nefrol; 1979; 26(3):243-50. PubMed ID: 318057
[No Abstract] [Full Text] [Related]
2. Circulating immune complexes in patients with glomerulonephritis and in renal transplant patients.
Sølling J
Scand J Urol Nephrol Suppl; 1985; 97():1-46. PubMed ID: 3915401
[No Abstract] [Full Text] [Related]
3. [Serial studies of serum immune complexes and complements in patients with glomerulonephritis].
Nakayama S; Koide H; Ohno J
Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):163-9. PubMed ID: 6611432
[No Abstract] [Full Text] [Related]
4. Immune complexes in SLE.
Inman RD
Clin Rheum Dis; 1982 Apr; 8(1):49-62. PubMed ID: 6214365
[No Abstract] [Full Text] [Related]
5. [Quantitative and qualitative determinations and clinical and histological correlations of cryoglobulins in glomerulonephritis].
Coppo R; Boero R; Cirone U; Basolo B; Giraudo G; Piccoli GB; Giacchino F; Giachino G; Rossano C; Piccoli G
Arch Sci Med (Torino); 1982; 139(4):399-405. PubMed ID: 6984819
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes in patients with IgA glomerulonephritis.
Nagy J; Füst G; Ambrus M; Trinn C; Paál M; Burger T
Acta Med Acad Sci Hung; 1982; 39(3-4):211-8. PubMed ID: 6985242
[TBL] [Abstract][Full Text] [Related]
7. Immune complexes in diabetes mellitus: studies of complement utilisation and tissue deposition.
Charlesworth JA; Campbell LV; Catanzaro R; Pussell BA; Pasterfield GV; Peake P
J Clin Lab Immunol; 1982 Sep; 8(3):163-8. PubMed ID: 6752415
[No Abstract] [Full Text] [Related]
8. [Methods of determining circulating immune complexes].
Baleva M
Vutr Boles; 1983; 22(6):1-5. PubMed ID: 6369791
[No Abstract] [Full Text] [Related]
9. Complement activation and C1q binding activity in haemodialysis.
Dodd NJ; Vergani D; Turney JH; Parsons V; Weston MJ
Proc Eur Dial Transplant Assoc; 1981; 18():300-4. PubMed ID: 6977138
[No Abstract] [Full Text] [Related]
10. [Determination of immunocomplexes. III. A method using a solid surface for immunocomplex binding and use of C1q subcomponent of the first complement component (C1q SP)].
Votruba T; Rákosník P
Cesk Epidemiol Mikrobiol Imunol; 1988 Feb; 37(1):15-22. PubMed ID: 2967114
[No Abstract] [Full Text] [Related]
11. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
Mirapeix E; Yagüe J; Vives J; Revert L
Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
[TBL] [Abstract][Full Text] [Related]
12. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
[TBL] [Abstract][Full Text] [Related]
13. [Circulating immune complexes following long-term physical work].
Dufaux B; Höffken K; Order U
Fortschr Med; 1985 Jan; 103(4):59-61. PubMed ID: 3871721
[No Abstract] [Full Text] [Related]
14. [Detection of circulating immune complexes by the C1q complement fraction deviation test. 1st application in the study of human glomerulopathies].
Sobel A; Gabay Y; Lagrue G
Nouv Presse Med; 1976 Jun; 5(23):1465-9. PubMed ID: 132639
[TBL] [Abstract][Full Text] [Related]
15. Circulating immune complexes in breast cancer patients.
Croce MV; Pasqualini RS; Segal-Eiras A
Medicina (B Aires); 1987; 47(4):371-6. PubMed ID: 3502571
[No Abstract] [Full Text] [Related]
16. The detection of complement binding immune complexes by means of 51Cr-labelled indicator cells.
Varga A; Kasper M; Stosiek P
Allerg Immunol (Leipz); 1986; 32(3):205-14. PubMed ID: 2947445
[TBL] [Abstract][Full Text] [Related]
17. [Use of the C1q binding assay in the analysis of immune complexes: personal experiences with its clinical use and future prospectives].
Corvetta A; Spaeth PJ; Panico F; Ghirelli PA; Orecchioni F; Danieli G
G Clin Med; 1983; 64(9-10):337-48. PubMed ID: 6198235
[No Abstract] [Full Text] [Related]
18. The classical complement pathway: mechanism of activation of the first component by antigen-antibody complexes.
Loos M
Prog Allergy; 1982; 30():135-92. PubMed ID: 7041131
[No Abstract] [Full Text] [Related]
19. The use of TNP-conjugated polyacrylamide beads in a C1q binding inhibition test for circulating immune complexes.
Schmidt R; Walther S; Sodomann CP
Immunobiology; 1982; 162(2):153-64. PubMed ID: 6981581
[TBL] [Abstract][Full Text] [Related]
20. Incidence of circulating immune complexes in patients with acute poststreptococcal glomerulonephritis and in patients with streptococcal impetigo.
Mezzano S; Olavarría F; Ardiles L; López MI
Clin Nephrol; 1986 Aug; 26(2):61-5. PubMed ID: 3530567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
